Novel Implications of Prognostic Markers to Monitor the Disease: An Overview-Reference-Cited by-同舟云学术

Novel Implications of Prognostic Markers to Monitor the Disease: An Overview

Published:2023-01 Issue: Volume: Page:182-197
ISSN:
Container-title:Therapeutic Drug Targets and Phytomedicine For Triple Negative Breast Cancer
language:
Short-container-title:

Author:

Saxena Rohit¹,Gupta Ankit²,Singh Vikrant³,Kumar Sagar⁴,Mittal Rashmi⁴

Affiliation:

1. University of Coahuila,Food Research Department,Coahuila,Mexico,

2. University of Tasmania,Tasmania,Australia,

3. Royal College of Surgeons,Department of Surgery,,Dublin,Ireland,

4. Patanjali Research Institute,Patanjali Herbal Research Department,Haridwar,India,

Abstract

Apart from the absence of targeted therapies, poor prognosis in TNBC has affected the clinical outcome of the disease and has led to cause high mortality rate amongst diseased individuals. The discovery of potential biomarkers to determine the prognostic and predictive value may play a vital role in the development of an effective therapeutic approach and may improve the OS, DFS, and DMFS. This chapter highlighted the role of histological subtyping, lymph node status, lymphovascular invasion, miRNA, Ki-67, TILs, and BRCAness as prognostic markers of diseases. Nevertheless, patient selection and choice of treatment strategy will greatly impact the clinical efficacy of these prognostic markers but will remain to be a matter of further exploration.<br>

Publisher

BENTHAM SCIENCE PUBLISHERS

Reference76 articles.

1. Siegel R.L.; Miller K.D.; Jemal A.; Cancer statistics, 2017. CA Cancer J Clin 2017,67(1),7-30

2. la Mare J-A.; Contu L.; Hunter M.; Moyo B.; Sterrenberg J.; Dhanani K.; Mutsvunguma L.; Edkins A.; Breast cancer: current developments in molecular approaches to diagnosis and treatment. Recent Patents Anticancer Drug Discov 2014,9(2),153-175

3. Jiang Y.Z.; Liu Y.R.; Xu X.E.; Jin X.; Hu X.; Yu K.D.; Shao Z.M.; Transcriptome analysis of triple-negative breast cancer reveals an integrated mRNA-lncRNA signature with predictive and prognostic value. Cancer Res 2016,76(8),2105-2114

4. Liu Y.R.; Jiang Y.Z.; Xu X.E.; Yu K.D.; Jin X.; Hu X.; Zuo W.J.; Hao S.; Wu J.; Liu G.Y.; Di G.H.; Li D.Q.; He X.H.; Hu W.G.; Shao Z.M.; Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer. Breast Cancer Res 2016,18(1),33

5. Rakha E.A.; El-Sayed M.E.; Green A.R.; Lee A.H.S.; Robertson J.F.; Ellis I.O.; Prognostic markers in triple-negative breast cancer. Cancer 2007,109(1),25-32